Lactobacillus mucosae DPC 6426 as a bile-modifying and immunomodulatory microbe

Show simple item record Ryan, Paul M. Stolte, Ellen H. London, Lis E. E. Wells, Jerry M. Long, Sarah L. Joyce, Susan A. Gahan, Cormac G. M. Fitzgerald, Gerald F. Ross, R. Paul Caplice, Noel M. Stanton, Catherine 2019-11-26T05:59:28Z 2019-11-26T05:59:28Z 2019-02-08
dc.identifier.citation Ryan, P.M., Stolte, E.H., London, L.E., Wells, J.M., Long, S.L., Joyce, S.A., Gahan, C.G., Fitzgerald, G.F., Ross, R.P., Caplice, N.M. and Stanton, C. (2019) 'Lactobacillus mucosae DPC 6426 as a bile-modifying and immunomodulatory microbe'. BMC microbiology, 19(1), 33. (13 pp.). DOI:10.1186/s12866-019-1403-0 en
dc.identifier.volume 19 en
dc.identifier.issued 1 en
dc.identifier.startpage 1 en
dc.identifier.endpage 13 en
dc.identifier.doi 10.1186/s12866-019-1403-0 en
dc.description.abstract Lactobacillus mucosae DPC 6426 has previously demonstrated potentially cardio-protective properties, in the form of dyslipidaemia and hypercholesterolemia correction in an apolipoprotein-E deficient mouse model. This study aims to characterise the manner in which this microbe may modulate host bile pool composition and immune response, in the context of cardiovascular disease. Lactobacillus mucosae DPC 6426 was assessed for bile salt hydrolase activity and specificity. The microbe was compared against several other enteric strains of the same species, as well as a confirmed bile salt hydrolase-active strain, Lactobacillus reuteri APC 2587. en
dc.description.sponsorship Enterprise Ireland Commercialisation Fund (grant number CF/2013/3030A/B); Teagasc (Walsh Fellowship Scheme) en
dc.format.mimetype application/pdf en
dc.language.iso en en
dc.publisher BMC part of Springer Nature en
dc.rights © The Author(s). 2019 en
dc.rights.uri en
dc.subject Exopolysaccharide en
dc.subject Bile acid en
dc.subject Bile salt hydrolase (BSH) en
dc.subject Hypercholesterolaemia en
dc.subject CVD en
dc.title Lactobacillus mucosae DPC 6426 as a bile-modifying and immunomodulatory microbe en
dc.type Article (peer-reviewed) en
dc.internal.authorcontactother Catherine Stanton, APC Microbiome Ireland, University College Cork, Cork, Ireland. +353-21-490-3000 Email: en
dc.internal.availability Full text available en
dc.description.version Published Version en
dc.contributor.funder Teagasc en
dc.contributor.funder Seventh Framework Programme en
dc.contributor.funder Enterprise Ireland en
dc.contributor.funder Science Foundation Ireland en
dc.description.status Peer reviewed en
dc.identifier.journaltitle BMC Microbiology en
dc.internal.IRISemailaddress en
dc.identifier.articleid 33 en
dc.relation.project info:eu-repo/grantAgreement/EC/FP7::SP1::KBBE/289517/EU/Dietary Fibers supporting Gut and Immune Function - From polysaccharide compound to health claim/FIBEBIOTICS en
dc.relation.project info:eu-repo/grantAgreement/SFI/SFI Research Centres/12/RC/2273/IE/Alimentary Pharmabiotic Centre (APC) - Interfacing Food & Medicine/ en
dc.identifier.eissn 1471-2180

Files in this item

This item appears in the following Collection(s)

Show simple item record

© The Author(s). 2019 Except where otherwise noted, this item's license is described as © The Author(s). 2019
This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement